Profil
Mark Chadwick worked as a European Patent Attorney at J.A.
Kemp LLP.
He then worked as a Patent Counsel at Amsterdam Molecular Therapeutics (AMT) Holding NV from 2008 to 2013.
Chadwick received his undergraduate degree from the University of Cambridge and his doctorate from the University of East Anglia.
Anciens postes connus de Mark Chadwick
Sociétés | Poste | Fin |
---|---|---|
Amsterdam Molecular Therapeutics (AMT) Holding NV
Amsterdam Molecular Therapeutics (AMT) Holding NV Miscellaneous Commercial ServicesCommercial Services Amsterdam Molecular Therapeutics (AMT) Holding NV engages in the development of human gene based therapies. The company has a product pipeline of several gene therapy products in development for hemophilia B, acute intermittent porphyria, Parkinson's disease and SanfilippoB. It is expected to be finally dissolved in September 2012. Amsterdam Molecular Therapeutics (AMT) Holding was founded by Sander J. H. van Deventer and John J. P. Kastelein on March 20, 1998 and is headquartered in Amsterdam, Netherlands. | Conseiller Juridique Général | 11/03/2013 |
J.A. Kemp LLP
J.A. Kemp LLP Miscellaneous Commercial ServicesCommercial Services J.A. Kemp & Co. provides protection for patents, trade marks and intellectual property, under International, European and UK law. The company also provides legal advice in the areas of biotechnology, chemistry, electronics and engineering, patent assignments and trade marks. It has offices in the United Kingdom and Germany. The company is headquartered in London, UK. | Conseiller Juridique Général | - |
Formation de Mark Chadwick
University of Cambridge | Undergraduate Degree |
University of East Anglia | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
Amsterdam Molecular Therapeutics (AMT) Holding NV
Amsterdam Molecular Therapeutics (AMT) Holding NV Miscellaneous Commercial ServicesCommercial Services Amsterdam Molecular Therapeutics (AMT) Holding NV engages in the development of human gene based therapies. The company has a product pipeline of several gene therapy products in development for hemophilia B, acute intermittent porphyria, Parkinson's disease and SanfilippoB. It is expected to be finally dissolved in September 2012. Amsterdam Molecular Therapeutics (AMT) Holding was founded by Sander J. H. van Deventer and John J. P. Kastelein on March 20, 1998 and is headquartered in Amsterdam, Netherlands. | Commercial Services |
J.A. Kemp LLP
J.A. Kemp LLP Miscellaneous Commercial ServicesCommercial Services J.A. Kemp & Co. provides protection for patents, trade marks and intellectual property, under International, European and UK law. The company also provides legal advice in the areas of biotechnology, chemistry, electronics and engineering, patent assignments and trade marks. It has offices in the United Kingdom and Germany. The company is headquartered in London, UK. | Commercial Services |